Trachoma
References
Fry AM, Jha HC, Lietman TM, Chaudhary JSP, Bhatta RC, Elliott J, Hyde T, Schuchat A, Gaynor B, Dowell SF. Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal. Clin Infect Dis 2002:35;395-402. (exit site)
Lietman TM, Neuwelt MD, Gandhi NG, Dalmon CA, Benitah N. Trachoma research: It takes more than a village. Lancet. 2006 Feb 4;367(9508):395 (exit site)
Mabey DCW, Solomon AW, Foster A. Trachoma (seminar). Lancet 2003; 362: 223-229. (exit site)
Ngondi J, Onsarigo A, Matthews F, Reacher M, Brayne C, Baba S, Solomon AW, Zingeser J, Emerson PM. Effect of 3 years of SAFE (surgery, antibiotics, facial cleanliness, and environmental change) strategy for trachoma control in southern Sudan: a cross-sectional study. Lancet. 2006 Aug 12; 368( 9535): 589-95. (exit site)
O’Loughlin R, Fentie G, Flannery B, Emerson PM. Follow-up of a low cost latrine promotion programme in one district of Amhara, Ethiopia: characteristics of early adopters and non-adopters. Tropical Medicine and International Health; 2006, 11(9):1406-1415. (exit site)
WHO resources available at - http://www.who.int/blindness/causes/trachoma/en/ (exit site) |
